October 27, 2022 – Federal Register Recent Federal Regulation Documents

The Department of Veterans Affairs (VA) is announcing the availability of funds for supportive services grants under the Supportive Services for Veteran Families (SSVF) Program. This Notice of Funding Availability (NOFA) contains information concerning the SSVF Program; the renewal and new applicant supportive services grant application processes; and the amount of funding available. Awards made for supportive services grants will fund operations beginning October 1, 2023. Grant awards may be renewed for up to 3 years pending the availability of funds and grantee performance.

The Coast Guard is establishing a temporary safety zone for navigable waters of the Monongahela River Mile Marker 22-22.86 on October 27, 2022 and October 28, 2022 from 5 p.m. through 8 a.m. each day. The safety zone is needed to protect personnel, vessels, and the marine environment from potential hazards created by filming on a barge. Entry of vessels or persons into this zone is prohibited unless specifically authorized by the Captain of the Port Pittsburgh.

In accordance with the Paperwork Reduction Act of 1995, ED is proposing a new collection.

Defense Human Resources Activity publishes this Civilian Personnel Per Diem Bulletin Number 321. Bulletin Number 321 lists current per diem rates prescribed for reimbursement of subsistence expenses while on official Government travel to Alaska, Hawaii, the Commonwealth of Puerto Rico, and the possessions of the United States. The Fiscal Year (FY) 2022 lodging rate review for Alaska resulted in rate changes for multiple locations.

On September 28, 2022, the Environmental Protection Agency (EPA) published a final rule in the Federal Register approving revisions to the San Diego County Air Pollution Control District (SDAPCD) portion of the California State Implementation Plan (SIP). In that rulemaking, the EPA inadvertently included erroneous amendatory instructions codifying the replacement of the previously approved versions of Rules 20.1, 20.3, and 20.4. This document corrects the errors in the final rule's amendatory instructions.

The FAA proposes to supersede Airworthiness Directive (AD) 96- 12-11, which applies to all Canadair Model CL-215-1A10 airplanes. AD 96-12-11 requires repetitive inspections to detect discrepancies of the microswitches fitted at the water door actuator; replacement of any discrepant microswitch; and modification of the water door actuator switches, which terminates the repetitive inspections. Since the FAA issued AD 96-12-11, it has determined that the corrective actions of that AD have not been effective at mitigating the risk of uncommanded opening of the water doors. This proposed AD would continue to require the modification of the water door actuator switches. This proposed AD would also require modification of the water door solenoid valve common grounds, add airplanes to the applicability, and prohibit installing certain water door solenoid valve selector assemblies. The FAA is proposing this AD to address the unsafe condition on these products.

In accordance with the Paperwork Reduction Act of 1995, this notice announces the intention of the Foreign Agricultural Service (FAS) to request approval for an existing collection in use without an OMB control number for the Borlaug Fellowship Program.

The Food and Drug Administration (FDA) is announcing the issuance of an Emergency Use Authorization (EUA) (the Authorization) under the Federal Food, Drug, and Cosmetic Act (FD&C Act) in response to an outbreak of monkeypox. FDA has issued an Authorization for an in vitro diagnostic device as requested by Abbott Molecular, Inc. The Authorization contains, among other things, conditions on the emergency use of the authorized product. The Authorization follows the August 9, 2022, determination by the Secretary of Health and Human Services (HHS) that there is a public health emergency, or a significant potential for a public health emergency, that affects, or has a significant potential to affect, national security or the health and security of U.S. citizens living abroad, and that involves monkeypox virus. On the basis of such determination, the Secretary of HHS declared, on September 7, 2022, that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of infection with the monkeypox virus, including in vitro diagnostics that detect and/or diagnose infection with non-variola Orthopoxvirus, pursuant to the FD&C Act, subject to terms of any authorization issued under that section. The Authorization, which includes an explanation of the reasons for issuance, is reprinted in this document.

The Department of Commerce, in accordance with the Paperwork Reduction Act of 1995 (PRA), invites the general public and other Federal agencies to comment on proposed, and continuing information collections, which helps us assess the impact of our information collection requirements and minimize the public's reporting burden. The purpose of this notice is to allow for 60 days of public comment preceding submission of the collection to OMB.

On September 20, 2022, the U.S. Nuclear Regulatory Commission (NRC) received an application for an export license (XW030) from Perma- Fix Northwest Richland, Inc. (PFNW) seeking approval for a license to export of low-level radioactive waste to Nuklearna Elektrama Krsko d.o.o, in Slovenia. The NRC is providing notice of the opportunity to comment, request a hearing, and petition to intervene on PFNW's application.

The seventh iteration of the Prescription Drug User Fee Amendments (PDUFA VII) included as part of the FDA User Fee Reauthorization Act of 2022 highlights the goal of advancing and facilitating the development and timely approval of drugs and biological products for rare diseases, including rare diseases in children. The Food and Drug Administration (FDA or Agency) is announcing the Rare Disease Endpoint Advancement Pilot Meeting Program (RDEA Pilot Program) established under the seventh iteration of PDUFA that affords sponsors who are admitted into the RDEA Pilot Program additional engagement opportunities with the Agency to discuss efficacy endpoint development in rare disease drug and biological product development programs. Meetings under the program will be conducted by FDA's Center for Drug Evaluation and Research (CDER) or Center for Biologics Evaluation and Research (CBER) during fiscal years (FYs) 2023 to 2027. For each sponsor whose RDEA program proposal (RDEA proposal or proposal) is admitted into the program, up to four meetings that will provide an opportunity for medical product developers to discuss rare disease endpoint development will be held between the sponsor and CDER or CBER. To promote innovation and evolving science, novel endpoints developed through the RDEA Pilot Program may be presented by FDA (e.g., in a guidance or public workshop or on a public-facing website) as case studies, including novel endpoints for drugs that have not yet been approved or biological products that have not yet been licensed by FDA for a given indication.

In accordance with the Paperwork Reduction Act of 1995 (PRA), the Consumer Financial Protection Bureau (CFPB or Bureau) requests the extension of the Office of Management and Budget's (OMB's) approval of the existing information collection titled ``Survey Screening Question List.''

The Environmental Protection Agency (EPA) has submitted an information collection request (ICR), Generator Standards Applicable to Laboratories Owned by Eligible Academic Entities (EPA ICR Number 2317.04, OMB Control Number 2050-0204) to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act. This is a proposed extension of the ICR, which is currently approved through December 31, 2022. Public comments were previously requested via the Federal Register on May 2, 2022 during a 60-day comment period. This notice allows for an additional 30 days for public comments. A fuller description of the ICR is given below, including its estimated burden and cost to the public. An agency may not conduct or sponsor and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number.

The Environmental Protection Agency (EPA) has submitted an information collection request (ICR), Ethnicity, Race, Gender and Disability Form (EPA ICR Number 2717.01, OMB Control Number 2030-NEW) to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act. This is a request for approval of a new collection. Public comments were previously requested via the Federal Register on March 2, 2022, and another notice was published on April 21, 2022 to extend the public comment period to allow for a 60-day comment period on supplemental documents that were added to the docket. This notice allows for an additional 30 days for public comments. A fuller description of the ICR is given below, including its estimated burden and cost to the public. An agency may not conduct, or sponsor and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number.

Notice is hereby given, pursuant to the provisions of the rules and regulations of the U.S. Commission on Civil Rights (Commission), and the Federal Advisory Committee Act (FACA), that a briefing of the Massachusetts Advisory Committee to the Commission will convene via web conference on Tuesday, November 1, 2022, at 12:00 p.m. (ET). The purpose of the briefing is to hear from additional panelists on civil asset forfeiture. The public will have an opportunity to make comments towards the conclusion of the briefing. Meeting Date: Tuesday, November 1, 2022; at 12:00 p.m. (ET). Zoom Link (audio/video): https://tinyurl.com/3vtr9tj7. If Phone Only, Dial: 1-800-360-9505; Meeting ID: 161 046 1872#.

The Administration for Community Living (ACL) is announcing an opportunity for the public to comment on the proposed collection of information listed above. Under the Paperwork Reduction Act of 1995 (PRA), Federal agencies are required to publish a notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This is a new information collection request soliciting comments on the information collection requirements relating to the Office of Healthcare Information and Counseling (OHIC) Profiles project at ACL.

The Transportation Security Administration (TSA) will hold a public meeting of the Aviation Security Advisory Committee (ASAC) on December 1, 2022. Members of the ASAC will meet in person at the TSA Headquarters. A link to virtually participate in the meeting will be available to members of the public as discussed below under SUPPLEMENTARY INFORMATION/Public Participation. An agenda for the meeting can also be found under SUPPLEMENTARY INFORMATION.

The Commission will consider a Further Notice of Proposed Rulemaking that would ensure continued support for mobile carriers and extend the support phase down for incumbent fixed broadband providers in Puerto Rico and the U.S. Virgin Islands to enhance their networks' reliability and resiliency in the face of hurricanes and other natural disasters. 2.................. Wireless Tele- Title: Considering 12.7 GHz Communications and Band for Next-Generation Office of Engineering Wireless Services (GN & Technology. Docket No. 22-352). Summary: The Commission will consider a Notice of Inquiry to seek information on the current use of the 12.7-13.25 GHz band, ways to encourage more efficient and intensive use of the band, and whether the band is suitable for mobile broadband or other expanded use. The Commission will also consider an Order to extend the temporary freeze on applications in the 12.7 GHz band. 3.................. Wireline Competition.. Title: Caller ID Authentication on Non-IP Networks (WC Docket No. 17- 97). Summary: The Commission will consider a Notice of Inquiry launching a broad inquiry on caller ID authentication technology for non-Internet Protocol networks. 4.................. Public Safety & Title: Improving the Homeland Security. Security of the National Alert and Warning Systems (PS Docket No. 22-329); Amendment of Part 11 of the Commission's Rules Regarding the Emergency Alert System (PS Docket No. 15-94); Wireless Emergency Alerts (PS Docket No. 15-91). Summary: The Commission will consider a Notice of Proposed Rulemaking to strengthen the operational readiness of the Emergency Alert System and Wireless Emergency Alerts, including by reducing the vulnerability of these systems to cyberattacks. 5.................. Media................. Title: Restricted Adjudicatory Matter. Summary: The Commission will consider a restricted adjudicatory matter.

The Food and Drug Administration (FDA) is postponing the joint meeting of the Nonprescription Drugs Advisory Committee and the Obstetrics, Reproductive and Urologic Drugs Advisory Committee scheduled for November 18, 2022. Future meeting dates will be announced in the Federal Register.